# Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

> **NCT00947843** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 306 (actual)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** aspirin + pregrel (Clopidogrel resinate)
- **DRUG:** aspirin + placebo
- **DRUG:** aspirin + plavix (Clopidogrel bisulfate)

## Key facts

- **NCT ID:** NCT00947843
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2016-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947843, "Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00947843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*